Longitudinal analysis of organ-specific tumor lesion sizes in metastatic colorectal cancer patients receiving first line standard chemotherapy in combination with anti-angiogenic treatment-Reference-Cited by-同舟云学术

Longitudinal analysis of organ-specific tumor lesion sizes in metastatic colorectal cancer patients receiving first line standard chemotherapy in combination with anti-angiogenic treatment

Published:2020-08-31 Issue:6 Volume:47 Page:613-625
ISSN:1567-567X
Container-title:Journal of Pharmacokinetics and Pharmacodynamics
language:en
Short-container-title:J Pharmacokinet Pharmacodyn

Author:

Mercier Francois^ORCID,Kerioui Marion,Desmée Solène,Guedj Jeremie,Krieter Oliver,Bruno Rene

Funder

F. Hoffmann-La Roche

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s10928-020-09714-z.pdf

Reference26 articles.

1. Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247. https://doi.org/10.1016/j.ejca.2008.10.026

2. Ribba B, Holford NH, Magni P et al (2014) A review of mixed-effects models of tumor growth and effects of anticancer drug treatment used in population analysis. CPT Pharmacomet Syst Pharmacol 3:e113. https://doi.org/10.1038/psp.2014.12

3. Bruno R, Mercier F, Claret L (2014) Evaluation of tumor size response metrics to predict survival in oncology clinical trials. Clin Pharmacol Ther 95:386–393

4. Bruno R, Bottino D, de Alwis DP et al (2020) Progress and opportunities to advance clinical cancer therapeutics using tumor dynamic models. Clin Cancer Res 26:1–9. https://doi.org/10.1158/1078-0432.CCR-19-0287

5. Bendell JC, Sauri T, Cubillo Gracian A et al (2019) The McCAVE trial: vanucizumab plus mFOLFOX-6 versus bevacizumab plus mFOLFOX-6 in patients with previously untreated metastatic colorectal carcinoma (mCRC). Oncologist 24:1–9. https://doi.org/10.1634/theoncologist.2019-0291

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Organ-specific tumor dynamics predict survival of patients with metastatic colorectal cancer;European Journal of Cancer;2024-08

2. Nonlinear Multilevel Joint Model for Individual Lesion Kinetics and Survival to Characterize Intra-Individual Heterogeneity in Patients with Advanced Cancer;Biometrics;2023-07-27

3. Modeling tumor size dynamics based on real‐world electronic health records and image data in advanced melanoma patients receiving immunotherapy;CPT: Pharmacometrics & Systems Pharmacology;2023-06-16

4. Assessing the Increased Variability in Individual Lesion Kinetics During Immunotherapy: Does It Exist, and Does It Matter?;JCO Precision Oncology;2023-02

5. Modelling the association between biomarkers and clinical outcome: An introduction to nonlinear joint models;British Journal of Clinical Pharmacology;2022-02-03